Table 1.
Study | Country | Probands, n | Detection of Index Cases | Family Members, n | Contact and Collection | Testing |
---|---|---|---|---|---|---|
Bhatnagar et al14 | United Kingdom | 259 | SBR | 200 | Letter advising an appointment with PCP | Biochemical |
Umans-Eckenhausen et al16 | The Netherlands | 237 | Diagnostic protocol followed by GT | 5442 | Nurse home visit | LDLR+Biochemical |
Vergotine et al19 | South Africa | 379 | GT | 790 | … | LDLR |
Marks et al15 | United Kingdom | 227 | SBR | 165 | Letter with choice of home visit or an SAC visit | Biochemical |
Hadfield et al13 | United Kingdom | 733 | SBR | 769 | Letter advising an appointment with GP or to attend SAC | Biochemical |
Muir et al24 | New Zealand | 76 | GT | 353 | Letter advising to attend SAC | LDLR, APOB |
Bell et al17 | Australia | 100 | GT | 366 | Letter with telephone counseling and advice to attend SAC | LDLR, APOB, PCSK9 |
Jannes et al20 | Brazil | 248 | GT | 394 | Referral to SAC | LDLR, APOB, PCSK9 |
Latkovskis et al18 | Latvia | 140 | DLCN score | 68 | … | Biochemical |
Alver et al23 | Estonia | 21 | GT | 64 | Family member directed invite to SAC | LDLR, APOB, PCSK9 |
DLCN indicates Dutch Lipid Clinic Network; GP, general practitioner; GT, genetic testing; PCP, primary care provider; SAC, study-associated clinic; and SBR, Simon Broome Register.